Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9P5Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,128
Award facts
- Contract value 100% obligated
- $33,127.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,127.89 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Vraylar is a neurological treatment medication, consistent with the company's demonstrated capability to deliver specialty pharmaceuticals across multiple therapeutic domains through its DLA framework. The delivery order's one-day completion window reflects the expedited nature of pharmaceutical supply fulfillment under the prime vendor model, enabling rapid deployment of critical medications to federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9P5Q?
SPE2DR26F9P5Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F9P5Q worth?
The government has obligated $33,128 on SPE2DR26F9P5Q.
Is contract SPE2DR26F9P5Q an order under another contract?
Yes. SPE2DR26F9P5Q is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P5Q competed?
The extent of competition for SPE2DR26F9P5Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award